Page 174 - The Toxicology of Fishes
P. 174

154                                                        The Toxicology of Fishes


                           Amino Acid Conjugation .............................................................................................................205
                                Overview.............................................................................................................................205
                                Enzymes Specificity, Regulation, and Inhibition...............................................................206
                           Acetylation ...................................................................................................................................206
                                Overview.............................................................................................................................206
                                Enzyme Specificity, Regulation, and Inhibition.................................................................207
                       Toxicological Relevance ........................................................................................................................207
                           Benzo(a)pyrene ............................................................................................................................207
                           Aflatoxin B ..................................................................................................................................209
                                    1
                           Organophosphate Esters and Carbamates....................................................................................213
                       Conclusions............................................................................................................................................215
                       References..............................................................................................................................................216


                       Introduction

                       Biotransformation is a two-phase process catalyzed primarily through enzymatic reactions that often
                       radically alter the chemistry of nonpolar lipophilic chemicals to polar water-soluble metabolites pre-
                       dominately leading to detoxification and elimination of the parent compounds. Unfortunately, the alter-
                       ation of chemistry required for enhanced polarity often creates reactive intermediates through
                       bioactivation, which can be more biologically hazardous than the initial parent compounds. The phase I
                       process either adds or exposes polar atoms within a xeno- or endobiotic compound. Three general phase I
                       reactions include oxidation, reduction, and hydrolysis (Table 4.1). When polarity has been enhanced
                       through phase I reactions, phase II reactions generally attempt to further enhance polarity through
                       conjugation of the phase I product with a bulky polar endogenous molecule. Alternatively, phase II
                       reactions may protect against bioactivation by masking functional groups (i.e., amines) prone to reactive
                       intermediate formation with groups that likely provide steric hindrance (i.e., methyl, acetyl) rather than
                       augmented polarity (Table 4.1).



                       Phase I Reactions

                       Oxidation
                       Various enzymes are involved in the oxidation of xeno- and endobiotic compounds. Dehydrogenases oxidize
                       substrates transferring electrons to an electron-deficient acceptor that is typically an essential cofactor for
                                      +
                       catalysis (e.g., NAD ). Oxygenases catalyze the incorporation of molecular oxygen into molecules, and
                       water is the source of oxygen for oxidases. Peroxidases derive oxygen from peroxide cofactors.
                       Cytochrome P450 Family of Drug Metabolizing Enzymes
                       Overview
                       The most dominant enzyme system responsible for oxidation processes in phase I biotransformation is
                       the cytochrome P450 monooxygenases. The cytochrome P450s (CYPs) constitute a superfamily of heme-
                       containing proteins that catalyze biological oxidation and reduction reactions. Klingenberg (1958) and
                       Garfinkel (1958) first reported that hepatic microsomes contain a pigment that binds carbon monooxide
                       with an unusual visible absorption maximum at 450 nm in its CO-reduced difference spectrum. Omura
                       and Sato (1962) discovered that this pigment was a b-type cytochrome and called it cytochrome P450.
                       The hepatic microsomal CYP system has broad substrate specificity and is responsible for oxidative
                       metabolism of many structurally diverse endogenous and xenobiotic compounds. CYP  enzymes are
                       important for converting lipophilic foreign chemicals into more water-soluble products for excretion
                       and, hence, detoxification. On the other hand, CYP enzymes catalyze the conversion of certain com-
                       pounds such as polycyclic aromatic hydrocarbons (PAHs) and nitrosamines into more toxic intermediates.
                       Constitutive CYP forms that appeared early in evolution are involved in biosynthesis (anabolism) of
                       endogenous substances such as steroids, fatty acids, vitamins, bile acids, leukotrienes, thromboxanes,
   169   170   171   172   173   174   175   176   177   178   179